US Patent Issued to Takeda Pharmaceutical on Aug. 12 for "Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,854, issued on Aug. 12, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema" was invented by Daniel J. Sexton (Melrose, Mass.), Burt Adelman (Concord, Mass.), Yung Chyung (Lexington, Mass.), Christopher TenHoor (Hopkinton, Mass.), Jon A. Kenniston (Hingham, Mass.), Ryan Faucette (Melrose, Mass.), Ryan Iarrobino (Sterling, Mass.) and Joseph Biedenkapp (Acton, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are plasma kallikrein binding proteins such as antibodies binding to active plasma kallikrein and methods of using such proteins ...